Castle Biosciences' Tax Provisions fell 9808.75% to $115000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.7 million, marking a year-over-year decrease of 23258.94%. This contributed to the annual value of $3.3 million for FY2024, which is 318613.86% up from last year.
Per Castle Biosciences' latest filing, its Tax Provisions stood at $115000.0 for Q3 2025, which was down 9808.75% from -$4.7 million recorded in Q2 2025.
Castle Biosciences' Tax Provisions' 5-year high stood at $6.0 million during Q3 2024, with a 5-year trough of -$8.7 million in Q4 2021.
Moreover, its 5-year median value for Tax Provisions was $15000.0 (2023), whereas its average is -$754625.0.
Its Tax Provisions has fluctuated over the past 5 years, first plummeted by 3924000.0% in 2022, then skyrocketed by 1869062.5% in 2024.
Over the past 5 years, Castle Biosciences' Tax Provisions (Quarter) stood at -$8.7 million in 2021, then surged by 100.65% to $57000.0 in 2022, then tumbled by 31.58% to $39000.0 in 2023, then crashed by 4471.79% to -$1.7 million in 2024, then surged by 106.74% to $115000.0 in 2025.
Its Tax Provisions was $115000.0 in Q3 2025, compared to -$4.7 million in Q2 2025 and -$423000.0 in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value